malignant solid tumor
Conditions
Interventions
Sponsors
The First Affiliated Hospital of Harbin Medical University
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: (1) Aged 18 to 80 years old; (2) The research objects are patients with clinically suspected or confirmed tumors; (3) Participants who have completed 18F-FDG and 18F-FAPI PET/CT scans successively; (4) There is at least one measurable target lesion according to the RECIST1.1 standard; (5) Participants who can provide informed consent (signed by the participant, parent or legal representative), and agree in accordance with the guidelines of the clinical research ethics committee.
Exclusion criteria
Exclusion criteria: (1) Severe abnormal liver and kidney function; (2) Women who are preparing for pregnancy, pregnant and breast-feeding; (3) Those who cannot lie down for half an hour; (4) Suffer from claustrophobia or other mental illness; (5) Treatment has started between two PET scans; (6) Other situations considered by the investigator to be unsuitable for participating in the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Standard uptake value;Standard uptake value max;Standard uptake value mean;Standard uptake value Minimum;Metabolic tumor volume;total lesion glycolysis; | — |
Countries
China
Contacts
Public ContactZhehao Lyu
Department of Nuclear Medicine, The First Affiliated Hospital of Harbin Medical University
Outcome results
None listed